Mice with myeloid-specific G-protein-signaling modulator 1 (GPSM1) ablation were protected against high fat diet-induced insulin resistance, glucose dysregulation, and liver steatosis via repression of adipose tissue pro-inflammatory states.
[Nature Communications]
